Get the Stockscreener App
14.55
3.00%
-0.45
Anaptysbio Inc Stock (ANAB) Forecast
The Anaptysbio Inc (ANAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $28.19, representing a +93.76% increase from the current price of $14.55. The highest analyst price target is $28.11, and the lowest is $28.27.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ANAB Price Target
Average 20.83
(+43.13% Upside)
Is Anaptysbio Inc (ANAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 30.98 | Neutral |
| STOCH(9,6) | 11.44 | Buy |
| STOCHRSI(14) | 8.0624 | Buy |
| MACD(12,26) | -2.5716 | Sell |
| ADX(14) | 25.83 | Sell |
| William %R | -96.96 | Buy |
| CCI(14) | -76.99 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
16.96
Sell
|
16.95
Sell
|
| MA20 |
20.51
Sell
|
19.05
Sell
|
| MA50 |
24.03
Sell
|
23.13
Sell
|
| MA100 |
29.58
Sell
|
26.03
Sell
|
| MA200 |
27.36
Sell
|
26.18
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ANAB could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ANAB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 30.98 indicates that ANAB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.44 indicates that ANAB is oversold. This indicates that ANAB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.0624 indicates that ANAB is oversold. This suggests that ANAB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.83 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -76.99 indicates that ANAB is still oversold but not to an extreme extent.
Long-term ANAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anaptysbio Inc financial reports and earnings history, Anaptysbio Inc (ANAB) stock could reach $20.30 by 2030, $48.50 by 2040 and $122.74 by 2050. See the projected annual prices until 2050 of the Anaptysbio Inc stock below:
- Anaptysbio Inc (ANAB) is expected to reach an average price of $25.38 in 2035, with a high prediction of $24.58 and a low estimate of $24.38. This indicates an $74.44% rise from the last recorded price of $14.55.
- Anaptysbio Inc (ANAB) stock is projected to chart a bullish course in 2040, with an average price target of $49.48, representing an $240.09% surge from its current level. The forecast ranges from a conservative $49.07 to a sky-high $48.50.
- Our analysts predict Anaptysbio Inc (ANAB) to jump 460.06% by 2045, soaring from $82.59 to an average price of $81.49, potentially reaching $82.19. While $82.59 is the low estimate, the potential upside is significant.
- Anaptysbio Inc (ANAB) stock is expected to climb by 2050, reaching an average of $124.59, a $756.29% jump from its current level. However, a wide range of estimates exists, with high and low targets of $122.74 and $123.80, respectively, highlighting the market's uncertainty.
Anaptysbio Inc Stock (ANAB) Year by Year Forecast
Anaptysbio Inc Stock (ANAB) Price Forecast for 2025
Anaptysbio Inc Stock (ANAB) is expected to reach an average price of $20.83 in 2025, with a high prediction of $28.76 and a low estimate of $12.89. This indicates an +43.13% rise from the last recorded price of $14.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $28.82 | $28.27 | $28.11 | +98.10% |
| February, 2025 | $28.98 | $29.24 | $28.76 | +99.17% |
| March, 2025 | $28.84 | $28.06 | $27.49 | +98.22% |
| April, 2025 | $28.69 | $28.25 | $28.22 | +97.20% |
| May, 2025 | $25.02 | $25.37 | $27.43 | +71.95% |
| June, 2025 | $22.93 | $23.98 | $26.39 | +57.56% |
| July, 2025 | $19.29 | $23.07 | $21.30 | +32.58% |
| August, 2025 | $19.55 | $18.54 | $17.19 | +34.38% |
| September, 2025 | $21.91 | $20.82 | $21.72 | +50.58% |
| October, 2025 | $23.88 | $23.04 | $22.59 | +64.12% |
| November, 2025 | $24.67 | $25.06 | $24.13 | +69.53% |
| December, 2025 | $9.4275 | $12.89 | $23.23 | -35.21% |
Anaptysbio Inc Stock (ANAB) Price Forecast for 2026
The predicted value for Anaptysbio Inc (ANAB) in 2026 is set at an average of $11.15. Estimates vary from a peak of $15.02 to a trough of $7.2795, indicating an -23.36% surge from the present price of $14.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.67 | $10.38 | $11.88 | -12.89% |
| February, 2026 | $15.24 | $13.18 | $12.46 | +4.75% |
| March, 2026 | $11.51 | $14.05 | $15.02 | -20.91% |
| April, 2026 | $7.9181 | $8.1381 | $11.06 | -45.58% |
| May, 2026 | $15.14 | $9.7564 | $13.79 | +4.09% |
| June, 2026 | $15.37 | $14.79 | $14.63 | +5.65% |
| July, 2026 | $9.6122 | $10.92 | $13.69 | -33.94% |
| August, 2026 | $11.01 | $11.77 | $11.15 | -24.34% |
| September, 2026 | $8.7696 | $9.3354 | $9.6429 | -39.73% |
| October, 2026 | $10.78 | $9.5479 | $9.8862 | -25.94% |
| November, 2026 | $8.3028 | $8.9528 | $10.02 | -42.94% |
| December, 2026 | $6.2436 | $7.2795 | $6.857 | -57.09% |
Anaptysbio Inc Stock (ANAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anaptysbio Inc (ANAB) is $4.5846, with a high forecast of $8.9749 and a low forecast of $0.1943. This indicates an -68.49% decrease from the last price of $14.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.3402 | $5.7561 | $5.4278 | -70.17% |
| February, 2027 | $1.7369 | $0.3427 | $5.2473 | -88.06% |
| March, 2027 | $3.5524 | $2.3493 | $4.7924 | -75.59% |
| April, 2027 | $2.1557 | $0.1943 | $5.4982 | -85.18% |
| May, 2027 | $0.2091 | $0.4467 | $2.9574 | -98.56% |
| June, 2027 | $0.3817 | $1.2717 | $1.3649 | -97.38% |
| July, 2027 | $5.4683 | $2.1858 | $4.3983 | -62.42% |
| August, 2027 | $7.6749 | $5.5725 | $6.8549 | -47.25% |
| September, 2027 | $9.6057 | $8.1091 | $8.1057 | -33.98% |
| October, 2027 | $7.3823 | $8.5323 | $8.9749 | -49.26% |
| November, 2027 | $8.089 | $7.6289 | $7.5848 | -44.41% |
| December, 2027 | $1.6498 | $5.0698 | $7.5631 | -88.66% |
Anaptysbio Inc Stock (ANAB) Price Forecast for 2028
In 2028, Anaptysbio Inc (ANAB) is projected to reach an average price of $3.5114, with a high projection of $6.9896 and a low estimate of $0.0331. This indicates an -75.87% fall from the last price of $14.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6164 | $3.5239 | $3.4022 | -82.02% |
| February, 2028 | $1.523 | $2.513 | $0.4547 | -89.53% |
| March, 2028 | $2.3462 | $0.0696 | $2.6262 | -83.87% |
| April, 2028 | $2.0696 | $0.1646 | $5.3737 | -85.78% |
| May, 2028 | $3.6788 | $0.2245 | $4.433 | -74.72% |
| June, 2028 | $0.1278 | $1.3678 | $6.9896 | -99.12% |
| July, 2028 | $1.0955 | $0.7155 | $2.0697 | -92.47% |
| August, 2028 | $1.8052 | $0.0331 | $2.9872 | -87.59% |
| September, 2028 | $2.3419 | $2.5494 | $1.0385 | -83.90% |
| October, 2028 | $1.4285 | $1.9852 | $1.206 | -90.18% |
| November, 2028 | $4.0793 | $4.2226 | $3.5751 | -71.96% |
| December, 2028 | $2.0359 | $2.6059 | $3.6434 | -86.01% |
Anaptysbio Inc Stock (ANAB) Price Forecast for 2029
The 2029 price forecast for Anaptysbio Inc Stock (ANAB) is $10.29 on average, with a high prediction of $20.25 and a low estimate of $0.3364. This represents an -29.27% decrease from the previous price of $14.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.1367 | $3.0901 | $3.5725 | -85.31% |
| February, 2029 | $1.3733 | $2.0033 | $1.865 | -90.56% |
| March, 2029 | $1.4999 | $1.7616 | $1.2716 | -89.69% |
| April, 2029 | $1.7366 | $2.4865 | $2.0382 | -88.06% |
| May, 2029 | $5.7473 | $2.7581 | $2.889 | -60.50% |
| June, 2029 | $4.624 | $5.664 | $5.1748 | -68.22% |
| July, 2029 | $2.2194 | $0.3364 | $3.1894 | -84.75% |
| August, 2029 | $4.9286 | $1.6252 | $6.0369 | -66.13% |
| September, 2029 | $7.622 | $3.4162 | $7.872 | -47.62% |
| October, 2029 | $3.9512 | $3.8762 | $9.3578 | -72.84% |
| November, 2029 | $2.5746 | $1.7846 | $8.2187 | -82.31% |
| December, 2029 | $21.97 | $1.3004 | $20.25 | +51.00% |
Anaptysbio Inc Stock (ANAB) Price Forecast for 2030
Anaptysbio Inc Stock (ANAB) is expected to reach an average price of $50.26 in 2030, with a high forecast of $77.94 and a low forecast of $22.58. This signifies an +245.44% surge from the last price of $14.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.77 | $22.58 | $20.30 | +70.22% |
| February, 2030 | $39.16 | $38.71 | $38.59 | +169.17% |
| March, 2030 | $41.33 | $40.29 | $37.34 | +184.04% |
| April, 2030 | $51.79 | $45.05 | $51.21 | +255.95% |
| May, 2030 | $56.10 | $51.05 | $55.40 | +285.59% |
| June, 2030 | $52.07 | $54.15 | $55.79 | +257.84% |
| July, 2030 | $77.42 | $52.40 | $77.94 | +432.06% |
| August, 2030 | $72.63 | $73.14 | $75.60 | +399.15% |
| September, 2030 | $72.42 | $72.35 | $71.89 | +397.76% |
| October, 2030 | $71.31 | $71.40 | $72.31 | +390.07% |
| November, 2030 | $71.37 | $71.27 | $70.07 | +390.51% |
| December, 2030 | $71.10 | $71.88 | $70.81 | +388.68% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):